E
Vivani Medical, Inc. VANI
$1.01 -$0.01-0.98%
Recommendation
Sell
Prev Close
$1.02
Volume
90,022
Avg Vol (90D)
109,481
Market Cap
$60.42M
Dividend & Yield
--
52-Week Range
$1.00 - $2.22
P/E (TTM)
--
EPS (TTM)
-$0.4404
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Vivani Medical (NASDAQ:VANI) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS
4/1/2025 - MarketBeat
Vivani Medical Reports 2024 Financial Results and Business Progress
4/1/2025 - TipRanks Financial Blog
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial ...
3/31/2025 - GuruFocus
Vivani Medical GAAP EPS of -$0.11
3/31/2025 - SeekingAlpha.com: All News
Vivani Medical to focus on developing NPM-115, NPM-139, emerging pipeline
3/31/2025 - The Fly
Vivani Medical announces anticipated upcoming milestones
3/31/2025 - The Fly
Vivani Medical reports Q4 EPS (11c) vs. (12c) last year
3/31/2025 - The Fly
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
3/31/2025 - Globe Newswire
Vivani Medical (NASDAQ:VANI) Given Buy Rating at HC Wainwright
3/27/2025 - MarketBeat
Vivani Medical Announces $8.25M Private Placement Equity Financing
3/27/2025 - GuruFocus
Vivani Medical announces $8.25M private placement equity financing
3/27/2025 - Seeking Alpha - Healthcare
Vivani Medical announces $8.25M private placement equity financing
3/27/2025 - SeekingAlpha.com: All News
Vivani Medical prices 7.4M shares at $1.12 in private placement financing
3/27/2025 - The Fly
Vivani Medical Announces $8.25M Private Placement Equity Financing
3/27/2025 - Globe Newswire
Vivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment Soars
3/26/2025 - Stocktwits News Feed
Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, ...
3/26/2025 - GuruFocus
Vivani Medical announces preclinical weight loss data for NPM-139
3/26/2025 - The Fly
Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing
3/26/2025 - Globe Newswire
EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing
3/26/2025 - Benzinga
Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now
3/26/2025 - Globe Newswire
Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now
3/25/2025 - Globe Newswire
Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025
3/24/2025 - GuruFocus
Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025
3/24/2025 - Business Wire
Vivani Medical (VANI) Expected to Announce Quarterly Earnings on Tuesday
3/18/2025 - MarketBeat
What Makes Vivani Medical (VANI) a New Buy Stock
3/17/2025 - Zacks Investment Research
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$24.03M
EBIT (TTM)
-$24.43M
Net Income (TTM)
-$23.46M
Balance Sheet
Total Assets (Q)
$42.90M
Total Debt (Q)
$19.68M
Total Liabilities (Q)
$24.56M
Book Value Per Share (Q)
$0.3317
Cash Flow
Cash from Operations (TTM)
-$18.46M
Cash from Investing (TTM)
-$1.00M
Cash from Financing (TTM)
$14.25M
Net Change in Cash (TTM)
-$5.20M
Filings
Filing Date
Wednesday, November 13, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 24 and 28 (est)
Price History
Loading...
Beta
1.38
7-Day Total Return
-7.34%
30-Day Total Return
-15.13%
60-Day Total Return
-21.09%
90-Day Total Return
-21.71%
Year to Date Total Return
-15.83%
1-Year Total Return
-46.28%
2-Year Total Return
9.83%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 01, 2025 - $1.00
52-week High
Apr 08, 2024 - $2.22
Valuation
Market Cap
$60.42M - Micro Cap
Enterprise Value
$61.38M
Price/Sales (TTM)
--
Price/Book (Q)
3.08
Dividends and Shares
Shares Outstanding
55.25M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.vivani.com
Phone Number
415 506 8462
Address
1350 South Loop Road
Alameda, CA 94502
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal... more
NASDAQ 04/02/2025 4:00PM Eastern Quotes delayed
Weiss Ratings